Search

everythinglearnresearchcommunity

for

Search:↓

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

SHBG may be a useful early indicator and treatment target for PCOS.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Obese women with PCOS are more likely to have fatty liver disease.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Using psychological treatments can help manage skin conditions along with regular medical care.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.